(Q34164685)

31 July 2017

1 reference

title

Antibody-cytokine fusion proteins for the therapy of cancer. (English)

1 reference

31 July 2017

1 reference

Penichet ML

1

1 reference

31 July 2017

Morrison SL

series ordinal

2

1 reference

31 July 2017

language of work or name

1 reference

1 February 2001

1 reference

Journal of Immunological Methods

31 July 2017

published in

1 reference

31 July 2017

volume

248

1 reference

31 July 2017

issue

1-2

1 reference

31 July 2017

page(s)

91-101

1 reference

Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion-promoting surface glycoproteins on mature granulocytes

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

T cell-mediated eradication of murine metastatic melanoma induced by targeted interleukin 2 therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

An antibody-interleukin 2 fusion protein overcomes tumor heterogeneity by induction of a cellular immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Long-lived and transferable tumor immunity in mice after targeted interleukin-2 therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

IL-12 deaths: explanation and a puzzle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Treatment of recurrent squamous cell carcinoma of the head and neck with low doses of interleukin-2 injected perilymphatically

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Soluble and cell-associated transferrin receptor in lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Recombinant immunocytokines targeting the mouse transferrin receptor: construction and biological activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

The molecular cell biology of interferon-gamma and its receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Interleukin-12 induces interferon-gamma-dependent switching of IgG alloantibody subclass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

An IgG3-IL2 fusion protein activates complement, binds FcγRI, generates LAK activity and shows enhanced binding to the high affinity IL-2R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

An IgG3-IL-2 fusion protein has higher affinity than hrIL-2 for the IL-2R alpha subunit: real time measurement of ligand binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Gene therapy of metastatic cancer by in vivo retroviral gene targeting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Bioactive murine and human interleukin-12 fusion proteins which retain antitumor activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Interleukin-2 in cancer treatment: disappointing or (still) promising? A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Polyethylene-glycol-modified interleukin-2 is superior to interleukin-2 in locoregional immunotherapy of established guinea-pig tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Bifunctional fusion between nerve growth factor and a transferrin receptor antibody

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Incidence and prevalence of neutralizing antibodies to the common adenoviruses in children with cystic fibrosis: implication for gene therapy with adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Tumour regression after intralesional injection of interleukin 2 (IL-2) in bladder cancer. Preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Local interleukin-2 therapy in bovine ocular squamous cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Cancer vaccines: the interleukin 2 dosage effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

7 January 2021

Interleukin-2 toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Hepatocyte-directed gene delivery by receptor-mediated endocytosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Recombinant human granulocyte-macrophage colony-stimulating factor in patients with advanced malignancy: a phase Ib trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Breast cancer gene therapy: transgenic immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Inhibition of angiogenesis in vivo by interleukin 12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Effect of cloned interferon-gamma on expression of H-2 and Ia antigens on cell lines of hemopoietic, lymphoid, epithelial, fibroblastic and neuronal origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed IFN-gamma production by anti-tumor T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-1759%2800%2900345-8

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-1759(00)00345-8

1 reference

31 July 2017

1 reference